Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beata Piovesan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Medical Genetics|March 19, 2011
Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasiaNadia Prigoda Lee, Donco Matevski, Daniela Dumitru, et al.
Human Mutation|March 13, 2009
Detection of mosaic RB1 mutations in families with retinoblastomaDiane Rushlow, Beata Piovesan, Katherine Zhang, et al.
Human Molecular Genetics|January 24, 2008
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastomaHelen Dimaras, Vikas Khetan, William Halliday, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Medical Genetics|March 19, 2011
Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasiaNadia Prigoda Lee, Donco Matevski, Daniela Dumitru, et al.
Human Mutation|March 13, 2009
Detection of mosaic RB1 mutations in families with retinoblastomaDiane Rushlow, Beata Piovesan, Katherine Zhang, et al.
Human Molecular Genetics|January 24, 2008
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastomaHelen Dimaras, Vikas Khetan, William Halliday, et al.
Cancer Genetics|June 20, 2016
Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaHilary Racher, Sameh Soliman, Bob Argiropoulos, et al.
Pageof 1